Organo Corporation

Organo Corporation

ORGJF

$82.00

Updated: 23/09/2026, 08:27:53

Market Cap
$3.77B
Sector
Industrials
Industry
Industrial - Machinery
Country
JP
Stock valuation chart
One-year closing share-price history for ORGJF
Company Profile

Organo Corporation, headquartered in Tokyo, Japan, is a global leader in water treatment engineering. Established in 1941 and known as Japan Organo Co., Ltd. until its name change in 1966, the company operates across two primary business segments: Water Treatment Engineering and Performance Products. Its extensive product portfolio in water treatment engineering encompasses a wide array of systems designed for producing various grades of purified water. These include diverse pure water systems such as reverse osmosis (RO) units, automatic and manual regenerative systems, electric regeneration units, compact desktop and larger cabinet models, advanced electrode ionization high-purity systems, cartridge purifiers, and two-stage RO setups. For even higher purity requirements, Organo provides ultrapure water systems, including desktop and cabinet designs, alongside final polishing units. Beyond full systems, the company supplies essential related equipment and consumables. This includes alkaline electrolyzed water production equipment, homogenizers, and precision measurement tools like electro conductivity and resistivity meters, as well as ion exchange filters. Organo also manufactures a range of water, wastewater, and RO water treatment chemicals, alongside a comprehensive selection of industrial filters, covering types like micro, sanitary, polypropylene, plastic housing, RO wound, PF cartridge, capsule, and PF carbon filters. Additionally, commercial water purifiers are part of their offering. Organo Corporation extends its expertise to specialized industry applications. For the electronics sector, they deliver advanced ultrapure and multi-functional water production, wastewater treatment, valuable resource recovery, and organic solvent refining systems. They also contribute to public infrastructure with water supply and sewage treatment facilities. The pharmaceutical industry benefits from their purified water production and supply systems, UF water production and supply systems, water for injection (WFI) systems, and specialized pharmaceutical water system consulting. Furthermore, their capabilities include solutions for industrial plants, such as condensate filters and demineralizers, reactor and fuel pool cleanup systems, makeup water systems, and general wastewater treatment. The company also supplies equipment and systems for sugar refining.

USD
OTC
CEO: Masayuki Yamada
Employees: 2,658
https://www.organo.co.jp
Asset Summaries
Latest generated summaries for ORGJF

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for ORGJF.
Share price
$82.00
Market cap
$3.77B
Exchange
OTC
Currency
USD
CEO
Masayuki Yamada
Employees
2,658
IPO date
13/04/2022
Beta
1.307
Last dividend
$0.00
Day range
$82.00 – $82.00
52-week range
$53.03 – $113.69
1-day performance
0.00%
1-year performance
54.63%
Current drawdown (1Y)
-27.87%
CIK
0002142762
CUSIP
N/A
ISIN
JP3201600008
Created
07/12/2025, 05:37:36
Last update
23/09/2026, 08:27:53

Track Organo Corporation with an AI analyst

See which prediction-market events move ORGJF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to ORGJF from your Railway `news_articles` table.

No news found for this symbol.